Staff

Carol Cogliani, Ed.M., M.P.H.
Susan Foster, Ph.D.
Ronald Lanoue, M.B.A.
Stuart B. Levy, M.D.
Bonnie Marshall, M.T.
Thomas F. O’Brien, M.D.
Dorothy Jessica Ochieng, M.Sc.  
Kathleen T. Young 
 

Carol Cogliani, Ed.M., M.P.H.

APUA Program Manager. Ms. Cogliani is currently working on a project to strengthen scientific evidence to control misuse of antibiotics in agriculture and serving as project liaison/coordinator for ISRAR – International Surveillance on Reservoirs of Antibiotic Resistance. Ms. Cogliani’s former work at APUA included coordinating the development of the 2005 Report of the Global Advisory on Antibiotic Resistance Data (GAARD), implementing the first phase of the Reservoirs of Antbiotic Resistance (ROAR) project, initiating a small grants program for developing countries, and developing grant proposals for capacity-building projects in Africa and S.E. Asia. Ms. Cogliani has extensive experience in planning, implementing and evaluating innovative health research and educational programs for Harvard Medical School, Harvard School of Public Health, the International Rescue Committee, and the U.S. Peace Corps.  She studied at both Harvard University School of Public Health and Harvard Graduate School of Education, focusing on health policy and management at the former, and individual and organizational change at the latter.  Ms. Cogliani has studied and worked in the South Pacific and Paris.


Susan Foster, Ph.D.

APUA Director of Public Policy and Education.  Dr. Foster is a specialist in pharmaceutical policy and economics with extensive experience at the WHO Essential Drugs Programme and at the World Bank’s Population, Health and Nutrition Department.  She has published peer-reviewed articles on infectious disease research and economic and policy issues, including several guest editorials in the Lancet.  Dr. Foster has extensive field experience in Africa and other resource-poor countries, utilizing qualitative and quantitative research to produce reports on cost-effectiveness of health systems and cost-benefit analysis of various options.  Dr. Foster is PI of the APUA Gates Foundation project. She was the first coordinator of the London School of Hygiene & Tropical Medicine’s distance learning program and is a Professor of International Health at Boston University.


Ronald Lanoue, M.B.A.

Operations Manager of APUA. Mr. Lanoue is responsible for developing and implementing systems for financial analysis and program support to ensure the smooth operations of APUA. Mr. Lanoue has extensive experience supporting large USAID and NIH grants and has held senior administrative positions with various medical provider groups and organizations. He has extensive experience in developing and implementing computer and scheduling systems. He received his MBA from Boston University's School of Management, and is also conversant in French.


Stuart B. Levy, M.D.

APUA Board Chairman and founder and a past president of the American Society for Microbiology. A microbiologist and physician, Dr. Levy discovered the mechanism for tetracycline resistance (efflux) and was among the first to document the transfer of drug resistance among animals and humans. Dr. Levy is the author of The Antibiotic Paradox: How Miracle Drugs Are Destroying the Miracle, which has been widely cited in both the lay and scientific media and is in its second edition (2002). As a young physician, he worked extensively in the developing world. He has also written more than 250 scientific and medical papers and served as advisor on policy committees including: the NIH Fogarty Center’s three year study of Antibiotic Use and Resistance Worldwide (as Chairman); an advisory panel for the U.S. Office of Technology; the EPA Subcommittees on Health and Antibiotic Resistance; the UK House of Lords report on antibiotic resistance; and WHO Scientific Advisory Groups. Dr. Levy has also served as a consultant for the World Health Organization, the U.S. FDA, the National Institutes of Health, the U.S. AMRIID national security project, and other national and international organizations including official national biosecurity panels. Dr. Levy has been featured and quoted for his work on antibiotic use and resistance in major national and international newspapers and magazines including Time, Newsweek, US News and World Report, New Yorker, New York Times, Washington Post, USA Today, Chicago Tribune, and San Francisco Chronicle. He has appeared on Good Morning America, Nova, the Today Show, Fox Front Page, ABC Prime Time, CBS 48 Hours, CNN, Canadian national television, Japanese public television, and all major US television network news shows. He is currently a Professor of Medicine and Molecular Biology/Microbiology and the Director of the Center for Adaptation Genetics and Drug Resistance at Tufts University School of Medicine, and a Staff Physician at the New England Medical Center.


Bonnie Marshall, M.T.

APUA’s Research Scientist and Editorial consultant.  Ms. Marshall received her B.A. in Microbiology from the University of New Hampshire and a Medical Technology degree from Framingham State College.  As a Research Associate in the Department of Molecular Biology and Microbiology at Tufts University School of Medicine, Ms. Marshall has over 25 years experience in the management and execution of bench science projects and multiple peer-reviewed journal publications concerning the tracking and quantifying of antimicrobial resistance.  She serves as Associate Editor of the APUA Newsletter and microbiology specialist on AMROAR, AMRIID and several APUA projects.


Thomas F. O’Brien, M.D.

Vice President of APUA. Dr. O'Brien is a leading authority on antibiotic resistance control and surveillance. An infectious disease specialist and microbiologist, Dr. O’Brien helped develop the WHONET surveillance program. He also initiated the WHO Collaborating Center for Surveillance of Resistance to Antimicrobial Agents at Brigham and Women’s Hospital in Boston in 1985, which has established an international network of over 60 microbiology laboratories tracking AMR patterns and developing guidelines based on these data. Dr. O’Brien has performed field consultations to improve clinical services in African hospitals and served as an advisor on numerous national and international committees, including the NIH Task Force on Antibiotic Resistance (which he chaired from 1984 to 1986); the WHO Scientific Working Group on AMR (1981); the FDA’s Veterinary Medicine Advisory Committee (since 1994); the Office of Technology Assessment Advisory Panel on Impacts of Antibiotic-Resistant Bacteria; the Inter-Agency (FDA, CDC, USDA) Working Group on Antimicrobial Resistance; and the CDC Working Group on Drug-Resistant Streptococcus pneumoniae. He has also served as a consultant on antimicrobial resistance to WHO (in Geneva and Manila), PAHO, the British House of Lords, and the National Health Research Institute of Taiwan, among others. Medical Director of the Microbiology Laboratory at Brigham and Women’s Hospital for the past 20 years, Dr. O’Brien has been a pioneering researcher in the area of AMR since the mid-1960s.
 

Dorothy Jessica Ochieng, M.Sc.

APUA Project Manager.  Ms. Ochieng is a molecular microbiologist with an extensive experience in scientific database management. Ms. Ochieng is working on the Gates Foundation situational analysis project in Africa. She also coordinates various surveillance project activities including the AMROAR project investigating antibiotic resistance in commensal organisms and the environment. Prior to joining APUA, Ms. Ochieng worked on a collaborative Biotechnogenomics project involving academic and industrial groups. In the Biotechnogenomics project, she assessed “the comparative amino acid metabolism in two different bacterial systems, E. coli and Bacillus strains.” She has also coordinated various projects and training programs on enteropathogenic microbes.
 

Kathleen T. Young

Chief Executive Officer of APUA.  Ms. Young has over 25 years of experience in executive administration of health care payer, provider, consumer, and governmental organizations. Ms. Young is responsible for development, implementation, and evaluation of APUA’s operations, programs and strategic initiatives. In that role she directs the board in strategic planning and staff in health services research, policy, and education projects.  Ms. Young is currently serving a four-year term as Consumer Representative of the U.S. FDA Anti-Infective Drugs Advisory Group, where she advises the FDA on new antimicrobials; review proposed protocols and assesses results of clinical trials. During her 10 year tenure at APUA, Ms. Young has developed collaborative projects enjoining  diverse stakeholders and funders, including major global foundations, government agencies, and corporations.  Ms. Young was formerly the president of a health consumer advocacy group and Director of Strategic Planning at several health service organizations including the Massachusetts Hospital Association, State of Massachusetts Office of Health Planning, National Medical Care, and Blue Cross/Blue Shield.  Ms. Young’s Master’s training was in public administration and health policy at the University of Chicago.



 

 
2013 Alliance for the Prudent Use of Antibiotics | 200 Harrison Ave, Posner 3 (Business), Boston, MA, 02111 | Tel 617.636.0966 | apua@tufts.eduHome | Search | Contact Us